# Study of Quadrivalent Influenza Vaccine Among Children

> **NCT01240746** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 4363 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Licensed 2010-2011 Trivalent Influenza Vaccine, No Preservative
- **BIOLOGICAL:** Investigational Trivalent Influenza Vaccine with alternate B strain, No Preservative
- **BIOLOGICAL:** Quadrivalent Influenza Vaccine, No Preservative

## Key facts

- **NCT ID:** NCT01240746
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-12
- **Final completion:** 2012-02
- **Target enrollment:** 4363 (ACTUAL)
- **Last updated:** 2015-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01240746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01240746, "Study of Quadrivalent Influenza Vaccine Among Children". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01240746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*